Sarolan

Products

Sarolaner was approved in the EU in 2015 and in many countries in 2017 in the form of chewable tablets for dogs (Simparica).

Structure and properties

Sarolaner (C₂₃H₁₈Cl₂F₄N₂O₅S, M_r = 581.4 g/mol) belongs to the isoxazoline group.

Effects

Sarolaner (ATCvet QP53BX06) has antiparasitic properties against fleas, ticks, and mites.

Indications

For the treatment of infestation of the following parasites in dogs:

• Ticks: , , ,
• Fleas: ,
• Scabies mites: